SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.
Han AX, Toporowski A, Sacks JA, Perkins MD, Briand S, van Kerkhove M, Hannay E, Carmona S, Rodriguez B, Parker E, Nichols BE, Russell CA.
Han AX, et al. Among authors: hannay e.
medRxiv [Preprint]. 2022 Sep 16:2022.05.20.22275319. doi: 10.1101/2022.05.20.22275319.
medRxiv. 2022.
PMID: 35664998
Free PMC article.
Updated.
Preprint.